VALOS

Executive Summary

VALOS is an Italian clinical research services company based in Milan, founded in 2007. It specializes in outsourced data management, biostatistics, statistical programming, and regulatory compliance for pharmaceutical and biotech sponsors. By offering precision, adherence to deadlines, and customer-centric solutions, VALOS positions itself as a reliable partner in ensuring clinical trial success. The company operates in the digital health and AI/machine learning categories, indicating a focus on leveraging technology to enhance its statistical and data services. Despite a lack of disclosed funding rounds or valuation, VALOS maintains a steady presence in the contract research organization (CRO) space, serving clients in the competitive European biopharma landscape. VALOS's value proposition lies in its deep domain expertise and ability to navigate complex regulatory requirements, which are critical for clinical trials. As the industry moves toward decentralized trials and AI-driven analytics, VALOS could capitalize on these trends to expand its service offerings. However, without public pipeline or financial disclosures, the company's growth trajectory remains uncertain. Its long tenure since 2007 suggests resilience, but its small scale may limit its ability to compete with larger global CROs. The company's conviction score reflects a moderate outlook given the lack of recent catalysts or visibility into its operational performance.

Upcoming Catalysts (preview)

• Q2 2026Adoption of AI-Powered Statistical Tools60% success
• Q4 2026EU Clinical Trials Regulation (CTR) Implementation Impact70% success
• Q3 2026Strategic Partnership with a Mid-Sized Pharma40% success